The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage

Nicola Scichilone, Blasi, Fabiano Di Marco, Fulvio Braido, Pierachille Santus

Risultato della ricerca: Article

6 Citazioni (Scopus)

Abstract

Lower respiratory tract infections (LRTIs), including pneumonia and acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD), are among the most common diagnoses in both outpatient and inpatient settings. Due to the burden of LRTIs healthcare providers must adopt practices focused on improving outcomes with the aim to reduce treatment failure and antibiotic resistances. Moreover, the role of acute and chronic infection in the pathogenesis of COPD has received considerable attention, since chronic infection can contribute to airways inflammation and COPD progression. This review discusses the role of cefditoren for the treatment of LRTIs, compared with the definition of "appropriate" of the WHO as "the cost-effective use of antimicrobials which maximizes clinical therapeutic effect while minimizing both drug-related toxicity and the development of antimicrobial resistance".
Lingua originaleEnglish
pagine (da-a)321-332
Numero di pagine12
RivistaEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Volume18
Stato di pubblicazionePublished - 2014

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Fingerprint Entra nei temi di ricerca di 'The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage'. Insieme formano una fingerprint unica.

  • Cita questo